A DESIGN FOR PHASE-II TESTING OF ANTICANCER AGENTS WITHIN A PHASE-III CLINICAL-TRIAL

被引：18

|

作者：

SCHAID, DJ ^{[1
]}

INGLE, JN ^{[1
]}

WIEAND, S ^{[1
]}

AHMANN, DL ^{[1
]}

机构：

[1] MAYO CLIN & MAYO FDN,DIV MED ONCOL,ROCHESTER,MN 55905

来源：

CONTROLLED CLINICAL TRIALS | 1988年 / 9卷 / 02期

关键词：

D O I：

10.1016/0197-2456(88)90032-3

中图分类号：

R-3 [医学研究方法]; R3 [基础医学];

学科分类号：

1001 ;

摘要：

引用

收藏

页码：107 / 118

页数：12

相关论文

共 50 条

[1] DESIGN FOR PHASE-II TESTING OF NEW AGENTS WITHIN A PHASE-III TRIAL WITH CROSSOVER
SCHAID, DJ
INGLE, JN
AHMANN, DL
CONTROLLED CLINICAL TRIALS, 1987, 8 (03): : 296 - 297
[2] PIPERACILLIN SODIUM (A PHASE-III CLINICAL-TRIAL)
MACBETH, WAAG
JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 1981, 9 (05) : 353 - 359
[3] STUDENTS EXPERIENCE IN A PHASE-III CLINICAL-TRIAL
MARSHALL, LL
FRYE, RF
MURPHY, JE
AMERICAN JOURNAL OF HOSPITAL PHARMACY, 1990, 47 (05): : 1014 - &
[4] PHASE-II CLINICAL-TRIAL OF CYTEMBENA
不详
BIOMEDICINE, 1977, 26 (06): : 392 - 395
[5] EARLY TERMINATION OF A PHASE-II CLINICAL-TRIAL
HILSENBECK, SG
CONTROLLED CLINICAL TRIALS, 1988, 9 (03): : 177 - 188
[6] NEOCARZINOSTATIN - REPORT OF A PHASE-II CLINICAL-TRIAL
MCKELVEY, EM
MURPHY, W
ZANDER, A
BODEY, GP
CANCER TREATMENT REPORTS, 1981, 65 (7-8): : 699 - 701
[7] REMISSION IN PHASE-II AND PHASE-III CLINICAL-TRIALS - CRITERIA AND PREREQUISITES
EDLER, L
FLECHTNER, H
ONKOLOGIE, 1987, 10 (06): : 330 - 339
[8] APPLICABILITY OF PHASE-I TRIAL RESULTS IN THE DESIGN OF PHASE-II AND PHASE-III BIOLOGICAL RESPONSE MODIFIER TRIALS
PINSKY, CM
CANCER TREATMENT REPORTS, 1985, 69 (10): : 1171 - 1176
[9] AN EARLY PHASE-II CLINICAL-TRIAL OF REMOXIPRIDE IN SCHIZOPHRENIA
CHOUINARD, G
TURNIER, L
INTERNATIONAL JOURNAL OF NEUROSCIENCE, 1987, 32 (1-2) : 682 - 683
[10] SUPERFRACTIONATION - RATIONALE AND RESULTS OF A PHASE-II CLINICAL-TRIAL
DOUGLAS, BG
RADIATION RESEARCH, 1978, 74 (03) : 502 - 503

← 1 2 3 4 5 →